Request a QuoteSample Transmittal FormHave a Question?

Nitrosamine Analysis in Active Pharmaceutical Ingredients and Finished Drug Products

The FDA expects the evaluation of the risk of nitrosamines in active pharmaceutical ingredients and finished drug products. This white paper describes how to conduct a nitrosamine risk assessment and perform the analysis for nitrosamines in  APIs and drug products.

Want To Download This Document?

Fill Out This Form For Access

Thank You! Your Download Is Ready!
Download Full White Page
Oops! Something went wrong while submitting the form.